Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Agnosia 6Pain 5Breast Neoplasms 3Pain, Postoperative 2Cancer Pain 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Postoperative Cognitive Complications 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Chronic Pain 1

Interventions

Morphine 7Ketamine 5Fentanyl 4Sodium Chloride 3Saline Solution 3Lidocaine 3Educational Status 3Dexmedetomidine 3Cognitive Behavioral Therapy 3Anesthetics, Local 3Surveys and Questionnaires 2Pregabalin 2Mindfulness-Based Stress Reduction 2Hypnosis 2Bupivacaine 2Botulinum Toxins, Type A 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tianeptine 1siltuximab 1onabotulinum toxin A 1nabiximols 1morphine, naltrexone combination 1erenumab 1Yoga 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1Tramadol 1Therapeutics 1Telemedicine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chronic Pain × Analgesics, Opioid × Clear all
NCT01541124 2018-02-08

Morphine as First Drug for Cancer Pain

Federal University of São Paulo

Phase NA Completed
60 enrolled

Cancer Pain, Agnosia, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡